drug eluting beads
Showing 1 - 25 of >10,000
Colorectal Cancer Liver Metastases, Regorafenib Trial in Guangdong (Regorafenib and DIBIRI, Regorafenib)
Recruiting
- Colorectal Cancer Liver Metastases
- Regorafenib
- Regorafenib and DIBIRI
- Regorafenib
-
Guangdong, Guangzhou, ChinaBo Zhang
Mar 20, 2023
Liver Metastasis Colon Cancer Trial in Guangzhou (TACE and HAIC Combined With Regorafenib)
Not yet recruiting
- Liver Metastasis Colon Cancer
- TACE and HAIC Combined With Regorafenib
-
Guangzhou, Guangdong, Chinathe first affiliated hospital, Sun-Yat sen university
Oct 2, 2023
Colorectal Cancer, Liver Metastases Trial in Shanghai (Trans arterial chemoembolization with Irinotecan Drug-eluting Beads)
Not yet recruiting
- Colorectal Cancer
- Liver Metastases
- Trans arterial chemoembolization with Irinotecan Drug-eluting Beads
-
Shanghai, Shanghai, ChinaZhongshan Hospital Fudan University
Jun 2, 2021
NSCLC Trial (DEB-BACE(Drug-eluting beads bronchial arterial chemoembolization))
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- DEB-BACE(Drug-eluting beads bronchial arterial chemoembolization)
- (no location specified)
Apr 7, 2021
Hepatocellular Carcinoma Trial in Sohag (Doxorubicin-Eluting Beads)
Active, not recruiting
- Hepatocellular Carcinoma
- Doxorubicin-Eluting Beads
-
Sohag, EgyptSohag University Hospital
May 5, 2022
Unresectable Hepatocellular Carcinoma Trial in Guangzhou (dTACE-HAIC, HAIC, dTACE-HAIC protocol)
Recruiting
- Unresectable Hepatocellular Carcinoma
- dTACE-HAIC
- +3 more
-
Guangzhou, Guangdong, Chinathe Second Affiliated Hospital of Guangzhou Medical University
Feb 22, 2022
Glioma Trial in Angers, Hannover (CM-BC2 Irinotecan drug-eluting bead)
Terminated
- Glioma
- CM-BC2 Irinotecan drug-eluting bead
-
Angers, France
- +1 more
Apr 19, 2021
NSCLC Trial (Drug-eluting beads bronchial arterial chemoembolization, Programmed Cell Death Protein 1 Inhibitor)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Drug-eluting beads bronchial arterial chemoembolization
- Programmed Cell Death Protein 1 Inhibitor
- (no location specified)
Feb 17, 2022
Carcinoma, Hepatocellular Trial in Bologna (DEB-TACE, TAE)
Recruiting
- Carcinoma, Hepatocellular
- DEB-TACE
- TAE
-
Bologna, ItalyIRCCS Azienda Ospedaliero-Universitaria di Bologna
Mar 17, 2021
Lung Cancer, Hepatocellular Carcinoma, Solid Tumor Trial in Guangzhou (CpG-ODN)
Recruiting
- Lung Cancer
- +2 more
- CpG-ODN
-
Guangzhou, Guangdong, ChinaThe Second Affiliated Hospital of Guangzhou Medical University
Jun 27, 2021
HepatoCellular Carcinoma Trial (Trans-arterial chemoembolization (TACE), TACE with Drug Eluting Beads procedure)
Completed
- HepatoCellular Carcinoma
- Trans-arterial chemoembolization (TACE)
- TACE with Drug Eluting Beads procedure
- (no location specified)
Sep 27, 2020
Hepatocellular Carcinoma After Transarterial Chemoembolization
Completed
- Hepatocellular Carcinoma
- Hepatocellular Carcinoma by BCLC Stage
- Transarterial Chemoembolization
- (no location specified)
Mar 2, 2021
Glioma Trial in Birmingham (CM-BC2)
Terminated
- Glioma
- CM-BC2
-
Birmingham, United KingdomQueen Elizabeth Hospital, University Hospitals Birmingham NHS Fo
Apr 19, 2021
Intrahepatic Cholangiocarcinoma, Transarterial Chemoembolization, Apatinib Trial in Chengdu (DEB-TACE combined with apatinib and
Not yet recruiting
- Intrahepatic Cholangiocarcinoma
- +3 more
- DEB-TACE combined with apatinib and PD-1 antibody
-
Chengdu, Sichuan, ChinaSichuan Cancer Hospital and Research Institute
Apr 4, 2021
Hepatocellular Carcinoma Trial in Beijing (procedure, device, drug)
Recruiting
- Hepatocellular Carcinoma
- DEB-TACE
- +3 more
-
Beijing, ChinaBeijing Tsinghua Chang Gung Hospital
Feb 3, 2021
Unresectable Intrahepatic Cholangiocarcinoma Trial in Louisville (LC or ONCOZENE Bead with Gem-Cis or Gem-Carbo, Gem-Cis or
Completed
- Unresectable Intrahepatic Cholangiocarcinoma
- LC or ONCOZENE Bead with Gem-Cis or Gem-Carbo
- Gem-Cis or Gem-Carbo
-
Louisville, KentuckyUniversity of Louisville
Dec 14, 2021
Colon Cancer With Metastases to the Liver Trial in Argentina, United States (LC beads loaded with Irinotecan, Oxaliplatin,
Completed
- Colon Cancer With Metastases to the Liver
- LC beads loaded with Irinotecan
- +4 more
-
Huntsville, Alabama
- +9 more
Jun 9, 2021
Unresectable Intrahepatic Cholangiocarcinoma Trial (Camrelizumab, Gemcitabine Injection, Cisplatin injection)
Not yet recruiting
- Unresectable Intrahepatic Cholangiocarcinoma
- Camrelizumab
- +4 more
- (no location specified)
Feb 17, 2023
Critical Limb Ischemia Trial (Drug Eluting Temporary Spur Stent System, Percutaneous Transluminal Balloon Angioplasty)
Not yet recruiting
- Critical Limb Ischemia
- Drug Eluting Temporary Spur Stent System
- Percutaneous Transluminal Balloon Angioplasty
- (no location specified)
Nov 8, 2023
In-stent Restenosis Trial (Drug-eluting Coronary Spur Stent System)
Not yet recruiting
- In-stent Restenosis
- Drug-eluting Coronary Spur Stent System
- (no location specified)
Oct 31, 2023
Hepatocellular Carcinoma, Hepatoma, Liver Cell Carcinoma Trial in United States (DEB-TACE, Sorafenib)
Terminated
- Hepatocellular Carcinoma
- +2 more
- DEB-TACE
- Sorafenib
-
Birmingham, Alabama
- +5 more
Jan 25, 2021
Drug-eluting Stent, Coronary Artery Disease Trial in Suwon (Genoss® DES system, Genoss® Osfit system)
Recruiting
- Drug-eluting Stent
- Coronary Artery Disease
- Genoss® DES system, Genoss® Osfit system
-
Suwon, Korea, Republic ofAjou University Hospital
Sep 27, 2023
Liver Tumors Trial in Belgium, France, Netherlands (Radiation therapy, chemoembolization)
Terminated
- Liver Neoplasms
- Radiation therapy
- chemoembolization
-
Antwerp, Belgium
- +10 more
Jan 25, 2021
Chronic Coronary Syndrome Trial (Magic Touch drug eluting balloon based strategy, Drug-eluting stent-based strategy)
Not yet recruiting
- Chronic Coronary Syndrome
- Magic Touch drug eluting balloon based strategy
- Drug-eluting stent-based strategy
- (no location specified)
Jan 5, 2023
Hepatocellular Carcinoma, Hepatoma Trial in Baltimore (sorafenib, LC Bead-TACE)
Completed
- Hepatocellular Carcinoma
- Hepatoma
- sorafenib
- LC Bead-TACE
-
Baltimore, MarylandThe Johns Hopkins Hospital
Oct 15, 2021